Secondary efficacy endpoints include additional parameters of physical performance ( resistance , lung function , perceived exertion , level of physical activity and IPAQ-questionnaire ) , health-related quality of life ( EORTC QLQ C30-questionnaire ) , disease and treatment related symptoms ( Memorial Symptom Assessment Scale ) , biologic parameter ( e.g. body composition , blood values of immune system , chronic inflammation , glucose and lipid metabolisms ) , and parameter of efficacy of oncologic treatment .